Nippon Shinyaku CoTSE:4516 +2.48%90 Days Payable is 76.45 as of Mar. 2026, which is 29% below its 10-year median of 108.04. GuruFocus rates TSE:4516 with a GF Score™ of 90/100 and a GF Value™ of 円4,794.93 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 922 Drug Manufacturers companies, Nippon Shinyaku Co ranks better than 54.45% on this metric.
The historical rank and industry rank for Nippon Shinyaku Co's Days Payable or its related term are showing as below:
TSE:4516'
s Days Payable Range Over the Past 10 Years
Min: 52.88 Med: 108.04 Max: 164.37
Current: 99.04
During the past 13 years, Nippon Shinyaku Co's highest Days Payable was 164.37. The lowest was 52.88. And the median was 108.04.
TSE:4516's Days Payable is ranked better than 54.45% of 922
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs TSE:4516: 99.04
Nippon Shinyaku Co's Days Payable
declined
from Mar. 2025 (124.71) to Mar. 2026 (76.45).
It may suggest that Nippon Shinyaku Coaccelerated paying its suppliers.
Nippon Shinyaku Co Days Payable Related Terms
Nippon Shinyaku Co Days Payable Historical Data
* Premium members only.
The historical data trend for Nippon Shinyaku Co's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Shinyaku Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Nippon Shinyaku Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Nippon Shinyaku Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nippon Shinyaku Co (TSE:4516) has a Days Payable of 76.45 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nippon Shinyaku Co and its competitors. This is 29% below median its historical median of 108.04. Over the past decade, Nippon Shinyaku Co's Days Payable has ranged from 52.88 to 164.37. According to the industry distribution chart, Nippon Shinyaku Co ranks #420 out of 922 companies in the Drug Manufacturers industry, placing it in the top 45.6%.
Is Nippon Shinyaku Co's Days Payable too high?
Nippon Shinyaku Co's current Days Payable of 76.45 is 29% below median its 10-year median of 108.04. Over the past 10 years, this metric has ranged from a low of 52.88 to a high of 164.37. The Drug Manufacturers industry median Days Payable is 90.84. Nippon Shinyaku Co's value of 76.45 is 15.8% below this industry median. Based on the distribution chart, Nippon Shinyaku Co ranks #420 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Nippon Shinyaku Co has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nippon Shinyaku Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Shinyaku Co ranks #420 out of 922 companies for Days Payable. This puts Nippon Shinyaku Co in the upper half of its industry. The industry median Days Payable is 90.84. Nippon Shinyaku Co's value of 76.45 is 15.8% below this benchmark. Historically, Nippon Shinyaku Co's own Days Payable has ranged from 52.88 to 164.37 over the past decade. While the company's 10-year median is 108.04 vs. the industry median of 90.84, Nippon Shinyaku Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Shinyaku Co's current Days Payable of 76.45 is 15.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nippon Shinyaku Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Shinyaku Co's current Days Payable is 76.45, which is 29% below median its own 10-year median of 108.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Shinyaku Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Shinyaku Co (TSE:4516) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,794.93, compared to a current price of 円4,084.00 — trading 14.8% below its estimated fair value. The current Days Payable is 76.45, which is 29% below median its 10-year median of 108.04 and 15.8% below the Drug Manufacturers industry median of 90.84. Nippon Shinyaku Co's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nippon Shinyaku Co (TSE:4516), the current Days Payable is 76.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Shinyaku Co (TSE:4516) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Shinyaku Co stock appears to be undervalued.
The current stock price of 円4,084.00 is trading 14.8% below its estimated GF Value™ of 円4,794.93.
GuruFocus considers Nippon Shinyaku Co to be Modestly Undervalued.
Key valuation signals for TSE:4516:
Days Payable: 76.45 (29% below median its 10-year median of 108.04)
GF Value™: 円4,794.93 vs. price of 円4,084.00 (14.8% below fair value)
Industry Position: 15.8% below the Drug Manufacturers median (#420 of 922)
No single metric tells the full story. See the TSE:4516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
90GF Score
Get the complete analysis for TSE:4516
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4516 has been successfully added to your 
